Author

Lucie Arnould

Lyon 1 UniversitéORCID 0009-0000-1290-4603Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Lucie Arnould1 paper · Institut Agro Montpellier

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Frédéric CateziD· 1 shared Frederique Madeleine Penault-LlorcaiD· 1 shared Jean‐Jacques DiaziD· 1 shared Jérémy NériiD· 1 shared Laura Duranton· 1 shared Marie Alexandra AlbaretiD· 1 shared Nina Radosevic‐RobiniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Frédéric CatezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer Gene TherapyPeer-reviewedApr 1, 2026

Identification of ribosomal protein eL21 as a novel externalized protein and a potential target in triple negative breast cancer

Lucie Arnould, Nina Radosevic‐Robin, Laura Duranton…·Frédéric Catez

This study identifies eL21 as an externalized ribosomal protein in triple negative breast cancer cells and shows anti-eL21 antibodies induce anti-proliferative effects.

DOI 10.1038/s41417-026-01026-7

humanproteomics

𝕏 PostBluesky